Roquefort Therapeutics (LSE:ROQ) Price-to-Operating-Cash-Flow : (As of Jun. 10, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-10), Roquefort Therapeutics's share price is £0.049. Roquefort Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01. Hence, Roquefort Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Roquefort Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 3 years, Roquefort Therapeutics's highest Price-to-Operating-Cash-Flow Ratio was 6.00. The lowest was 0.00. And the median was 0.00.

LSE:ROQ's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.02
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Roquefort Therapeutics's Cash Flow from Operations per share for the six months ended in Dec. 2023 was £-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01.

Roquefort Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Roquefort Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roquefort Therapeutics Price-to-Operating-Cash-Flow Chart

Roquefort Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Roquefort Therapeutics Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	-	-	-	-	-

Competitive Comparison of Roquefort Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Roquefort Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roquefort Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roquefort Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Roquefort Therapeutics's Price-to-Operating-Cash-Flow falls into.

Roquefort Therapeutics Price-to-Operating-Cash-Flow Calculation

Roquefort Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.049	/	-0.013
	=

Roquefort Therapeutics's Share Price of today is £0.049.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Roquefort Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Roquefort Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Roquefort Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Roquefort Therapeutics (LSE:ROQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

ROQAF:USA

Address

85 Great Portland Street, First Floor, London, GBR, W1W 7LT

Website

https://www.roquefortplc.com

Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses that are at an early stage in the medical sector including Drug and vaccine development; Diagnostics; Immuno-therapy; and Cell and gene therapies. The principal activity of the Company is to develop pre-clinical next generation medicines focused on hard to treat cancers.

Roquefort Therapeutics (LSE:ROQ) Headlines

No Headlines